Braveheart Bio prices $382.5M IPO at $18 per share

Palantir reported a significant revenue surge, exceeding analyst expectations. The company secured numerous high-value deals, boosting its financial performance. US commercial and government sectors drove substantial revenue growth for Palantir. Executives highlighted customer preference for AI sovereignty over rival models. CEO Alex Karp emphasized the inherent dangers and need for AI regulation.

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…

Meet Akshath Anand, the Surrey Grade 9 student who built a wearable device that detects IV leaks before swelling begins; his first national science fair ended with gold